Brief: Medexus Pharmaceuticals Announces Deal For Gleolan In The United States

Medexus Pharmaceuticals

01/03/2022 12:38

March 1 (Reuters) - Medexus Pharmaceuticals Inc  MDP.TO :
    * MEDEXUS PHARMACEUTICALS ANNOUNCES DEAL FOR GLEOLAN IN THE
UNITED
STATES
    * MEDEXUS PHARMACEUTICALS INC - GLEOLAN GENERATED $3-4
MILLION
U.S. NET SALES IN FOURTH CALENDAR QUARTER OF 2021
    * MEDEXUS PHARMACEUTICALS INC - MEDEXUS HAS ACQUIRED
EXCLUSIVE
RIGHTS TO COMMERCIALIZE GLEOLAN IN UNITED STATES
    * MEDEXUS PHARMACEUTICALS INC -  WILL PAY NXDC ANNUAL
ROYALTY
PAYMENTS AND PERIODIC LOW- TO MID-SINGLE-DIGIT-MILLION DOLLAR
MILESTONE PAYMENTS
    * MEDEXUS PHARMACEUTICALS INC - NXDC WILL REMAIN SPONSOR OF
NEW
DRUG APPLICATION FOR GLEOLAN ON FILE WITH U.S. FDA

Source text for Eikon:  ID:nGNX7dS9T5 
Further company coverage:  MDP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))